Original Contributions |
From the Department of Internal Medicine II (Y.N., M.H., H.O., S.M., K.M., H.M., Y.T., K.O., T.H.) and Physiology (K.N.), Nagoya University School of Medicine, and Nagoya University School of Health Science (T.I.), Department of Internal Medicine II, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Correspondence to Yasushi Numaguchi, Department of Internal Medicine II, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. E-mail numa2{at}tsuru.med.nagoya-u.ac.jp
AbstractProstacyclin
(PGI2), a metabolite of arachidonic acid,
has the vasoprotective effects of vasodilation, anti-platelet
aggregation, and inhibition of smooth muscle cell proliferation. We
hypothesized that an overexpression of endogenous
PGI2 may accelerate the recovery from
endothelial damage and inhibit neointimal
formation in the injured artery. To test this hypothesis, we
investigated in vivo transfer of the PGI2 synthase (PCS)
gene into balloon-injured rat carotid arteries by a nonviral
lipotransfection method. Seven days after transfection, a significant
regeneration of endothelium was observed in the
arteries transfected with a plasmid carrying the rat PCS gene
(pCMV-PCS), but little regeneration was seen in those with the control
plasmid carrying the lacZ gene (pCMV-lacZ) (percent
luminal circumference lined by newly regenerated
endothelium: 87.1±6.9% in pCMV-PCS-transfected
vessels and 6.9±0.2% in pCMV-lacZ vessels, P<0.001).
BrdU staining of arterial segments demonstrated a
significantly lower incorporation in pCMV-PCS-transfected vessels
(7.5±0.3% positive nuclei in vessel cells) than in pCMV-lacZ
(50.7±9.6%, P<0.01). Moreover, 2 weeks after
transfection, the PCS gene transfer resulted in a significant
inhibition of neointimal formation (88% reduction in ratio
of intima/media areas), whereas medial area was similar among the
groups. Arterial segments transfected with pCMV-PCS
produced significantly higher levels of 6-keto-PGF1
, the
main metabolite of PGI2, compared with the segments
transfected with pCMV-lacZ (10.2±0.55 and 2.1±0.32 ng/mg tissue for
pCMV-PCS and pCMV-placZ, P<0.001). In conclusion, this
study demonstrated that an in vivo PCS gene transfer increased the
production of PGI2 and markedly inhibited
neointimal formation with accelerated
reendothelialization in rat carotid arteries after
balloon injury.
Key Words: prostacyclin prostacyclin synthase restenosis gene therapy balloon injury
This article has been cited by other articles:
![]() |
L. Lam Shang Leen, C. Filipe, A. Billon, B. Garmy-Susini, S. Jalvy, F. Robbesyn, D. Daret, C. Allieres, S. R. Rittling, N. Werner, et al. Estrogen-Stimulated Endothelial Repair Requires Osteopontin Arterioscler. Thromb. Vasc. Biol., December 1, 2008; 28(12): 2131 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yokouchi, Y. Numaguchi, R. Kubota, M. Ishii, H. Imai, R. Murakami, Y. Ogawa, T. Kondo, K. Okumura, D. E. Ingber, et al. l-Caldesmon Regulates Proliferation and Migration of Vascular Smooth Muscle Cells and Inhibits Neointimal Formation After Angioplasty Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2231 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Wilson, A. M. Roche, E. Kostetskaia, and E. M. Smyth Dimerization of the Human Receptors for Prostacyclin and Thromboxane Facilitates Thromboxane Receptor-mediated cAMP Generation J. Biol. Chem., December 17, 2004; 279(51): 53036 - 53047. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Numaguchi, K. Okumura, M. Harada, K. Naruse, M. Yamada, H. Osanai, H. Matsui, M. Ito, and T. Murohara Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries Cardiovasc Res, January 1, 2004; 61(1): 177 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Niwano, M. Arai, K. Tomaru, T. Uchiyama, Y. Ohyama, and M. Kurabayashi Transcriptional Stimulation of the eNOS Gene by the Stable Prostacyclin Analogue Beraprost Is Mediated Through cAMP-Responsive Element in Vascular Endothelial Cells: Close Link Between PGI2 Signal and NO Pathways Circ. Res., September 19, 2003; 93(6): 523 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haider, I. Lee, J. Grabarek, Z. Darzynkiewicz, and N. R. Ferreri Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor-Mediated G1 Shortening and Nitric Oxide-Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation Circulation, August 26, 2003; 108(8): 1015 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Park, H.-M. Yang, S.-W. Youn, H.-J. Yang, I.-H. Chae, B.-H. Oh, M.-M. Lee, Y.-B. Park, Y.-S. Choi, H.-S. Kim, et al. Constitutively Active Glycogen Synthase Kinase-3{beta} Gene Transfer Sustains Apoptosis, Inhibits Proliferation of Vascular Smooth Muscle Cells, and Reduces Neointima Formation After Balloon Injury in Rats Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1364 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada, Y. Numaguchi, K. Okumura, M. Harada, K. Naruse, H. Matsui, T. Ito, and T. Hayakawa Prostacyclin Synthase Gene Transfer Modulates Cyclooxygenase-2-Derived Prostanoid Synthesis and Inhibits Neointimal Formation in Rat Balloon-Injured Arteries Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Godecke, M. Ziegler, Z. Ding, and J. Schrader Endothelial dysfunction of coronary resistance vessels in apoE-/- mice involves NO but not prostacyclin-dependent mechanisms Cardiovasc Res, January 1, 2002; 53(1): 253 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khurana, J. F. Martin, and I. Zachary Gene Therapy for Cardiovascular Disease: A Case for Cautious Optimism Hypertension, November 1, 2001; 38(5): 1210 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Zachary Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1375 - C1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Agata, R. Q. Miao, K. Yayama, L. Chao, and J. Chao Bradykinin B1 Receptor Mediates Inhibition of Neointima Formation in Rat Artery After Balloon Angioplasty Hypertension, September 1, 2000; 36(3): 364 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Audoly, B. Rocca, J.-E. Fabre, B. H. Koller, D. Thomas, A. L. Loeb, T. M. Coffman, and G. A. FitzGerald Cardiovascular Responses to the Isoprostanes iPF2{alpha}-III and iPE2-III Are Mediated via the Thromboxane A2 Receptor In Vivo Circulation, June 20, 2000; 101(24): 2833 - 2840. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Zachary, A. Mathur, S. Yla-Herttuala, and J. Martin Vascular Protection : A Novel Nonangiogenic Cardiovascular Role for Vascular Endothelial Growth Factor Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1512 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Young, K. Mahboubi, A. Haider, I. Li, and N. R. Ferreri Cyclooxygenase-2 Is Required for Tumor Necrosis Factor-{alpha}- and Angiotensin II-Mediated Proliferation of Vascular Smooth Muscle Cells Circ. Res., April 28, 2000; 86(8): 906 - 914. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |